The era of big mergers and acquisitions is coming! Well-known drugstore chains have acquired 89 pharmacies in succession

Recently, an international management consulting firm issued a pre-judgment for the pharmaceutical retail industry, saying that "china's pharmacy market will enter an accelerated stage of development in the future, the market size is expected to reach 620 billion yuan by 2020, the average annual growth rate remains between 10% and 15% of the high."
, the chain rate and industry concentration of Chinese pharmacies will be further enhanced by policy-driven, capital intervention, large-scale competition and other factors.
and that's exactly what it is.
recently, Yifeng Pharmacy released its 2020 half-yearly report.
reported that by the end of the reporting period, the company had 5,137 stores (including 493 franchisees) and a net increase of 385 stores in the first half of the year.
, Yifeng stores cover Hunan, Hubei, Shanghai, Jiangsu, Jiangxi, Zhejiang, Guangdong, Hebei, Beijing, nine provinces and cities.
among the 4,644 direct chain stores of Yifeng Pharmacy, 3,707 pharmacies, or 79.82 percent of the total number of stores, have obtained the qualification of various types of "medical insurance fixed-point retail pharmacies".
It is worth noting that during the reporting period, Yifeng Pharmacy had four mergers and acquisitions in the same industry, of which 2 (involving 45 stores) were completed and 2 were in the process of delivery (involving 44 stores).
, the industry believes that China's retail pharmacy mergers and acquisitions integration era is accelerating.
in fact, in addition to Yifeng Pharmacy, the other three listed drugstore chains have also publicly stated that they have arranged for mergers and acquisitions to accelerate the pace of mergers and acquisitions and expansion.
As at the annual general meeting on May 15 this year, Lin Zhaoxiong, a unanimous director and general manager of China National Pharmaceuticals, said, "Under the outbreak, although the first quarter performance was affected by some, but our operating indicators are not reduced, the second half of the year will strive to recover the first half of the loss."
not only did the target set last year not move, but even the target was added.
" in addition, its board secretary Chen Changbing also said, "In 2020, the national medicine will continue to be in-depth layout throughout the country, covering blank areas, stable strong areas, so 2020 will further accelerate store expansion, the number of stores will be further increased on the existing basis."
" in addition, has been adopting a self-built expansion model, but also in the 2019 annual report disclosed that in the next three years, Sichuan and Chongqing region is the company's main focus to expand the region, Guangxi, Hainan is the second expansion area.
At the same time as opening its own stores, One Heart will further participate in the integration of industry assets, through the acquisition of regional high-quality pharmaceutical retail assets to open up the market, improve market share, accelerate the expansion of the Sichuan region, and strive to build Sichuan and Chongqing into the company's sales volume of large areas.
, the expansion is the main demand of listed pharmacy chains, which will also accelerate the entry of Chinese pharmacies into the era of big mergers and acquisitions.
, it is worth noting that after the rapid expansion of drugstore chains, how to stabilize stores, how to make the acquisition of new stores to survive and ensure profits, will become a listed company needs to think about the issue.